2 results
Approved WMOCompleted
To study the potential of baclofen as an anti-craving/relapse agent in GHB dependent patients.
Approved WMOCompleted
Primary Trial Objective:To assess the effect of reversal of neuromuscular blockade with sugammadex 4 mg.kg-1 compared with reversal according to usual care (neostigmine or spontaneous reversal) on the incidence of adjudicated postsurgical events of…